CHIMIA International Journal for Chemistry · 2007 · 167 citations · 5 references
MedicineMedicinal ChemistryOncologyChemotherapyOrganometallic ChemistryStructure-activity RelationshipsBreast Cancer PharmacotherapyHormonal Cancer TherapyBioorganometallic ComplexesBreast Cancer ChemotherapyBreast Cancer Endocrine TherapyChemical Structure-activity RelationshipsEstrogen Receptor SignalingEstrogen Receptor StatusHormone Receptor-positive Breast Cancer TherapyMedicinal Chemistry Applications
Depending on the presence or absence of the estrogen receptor in the cells, breast cancer today is often treated by endocrine therapy (tamoxifen) or chemotherapy, respectively. We present now a new paradigm for breast cancer treatment, taking advantage of concepts in bioorganometallic chemistry. In this way, we have synthesized molecules containing an organometallic moiety (ferrocene), and a biovector (hydroxytamoxifen), yielding compounds which display a new therapeutic spectrum consisting of antiestrogenicity and cytotoxicity. A structure–activity relationship study has shown that a ferrocene group, linked to a para-phenol group by a conjugated spacer, is a necessary motif for strong cytotoxic effects to be observed.
5
[Estrogens in the environment].
P Podrouzek, P Čepický · PubMed · 1986 · 324 citations
Organometallic chemistry of the transition elements
Choice Reviews Online · 1991 · 80 citations